Tempus ECG-Low EF vs DeepTek CXR Analyzer
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary objective is to rapidly screen for potential low left ventricular ejection fraction (LVEF ≤40%) in patients aged 40 or older using standard 12-lead ECGs. This tool is ideal for aiding clinicians in the early identification of individuals at risk of heart failure who may require further cardiac evaluation.
View Tempus ECG-Low EF →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you aim to significantly improve the efficiency and diagnostic accuracy of chest X-ray interpretation across a broad spectrum of lung, pleural, and cardiac pathologies. This solution is best suited for radiology departments seeking to reduce radiologist workload, accelerate workflow, and automatically highlight suspicious regions for comprehensive review.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Unknown | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer offers advanced features for workflow integration, including automatic identification, categorization, and highlighting of suspicious regions of interest, directly aiming to reduce radiologist workload by 30-50% and boost productivity by 2x-3x. While Tempus ECG-Low EF provides a clear binary output, DeepTek's comprehensive assistance within the radiologist's workflow provides a greater overall usability impact.
Clinical Value
DeepTek CXR AnalyzerBoth tools are FDA-cleared and address significant clinical needs. DeepTek CXR Analyzer explicitly states it improves diagnostic accuracy by detecting 28 findings across various pathologies, with a study showing it outperformed unaided human readers and improved sensitivity and AUROC for test readers. Tempus ECG-Low EF aids in identifying patients at risk of heart failure, but DeepTek's direct impact on diagnostic accuracy for a broader range of common pathologies gives it a slight edge in immediate clinical value.
Pricing & Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer offers more transparency regarding its pricing model, specifying 'Pay-per-use' and availability as a 'technology offering or an AI-assisted reporting service.' This provides potential customers with clearer options and a better understanding of the value alignment compared to Tempus ECG-Low EF, which only states 'contact vendor.'
Enterprise Readiness
DeepTek CXR AnalyzerBoth tools demonstrate strong enterprise readiness with HIPAA compliance, BAA availability, and FDA clearance. However, DeepTek CXR Analyzer explicitly offers flexible deployment options including both 'Cloud' and 'On-premise' with seamless DICOM-based PACS integration, providing greater adaptability for diverse healthcare IT environments.
Innovation
Tempus ECG-Low EFTempus ECG-Low EF demonstrates a more novel application of AI by using standard 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction, a condition typically assessed by more specialized imaging like echocardiography. This innovative approach leverages existing, widely available data for early risk identification. DeepTek's broad detection capabilities for chest X-rays are impressive, but the core concept of CADe for X-rays is more established.
Support & Docs
DeepTek CXR AnalyzerBoth companies provide clear contact information for customer support via email and phone. DeepTek, however, explicitly mentions a 'Resources Hub' that includes a 'Gateway Download & Installation Guide' and actively recruits for a Technical Support Engineer with expertise in DICOM and system integration, suggesting a more robust and specialized technical documentation and support structure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | DeepTek CXR Analyzer |
|---|---|---|
| Name | Tempus ECG-Low EF | DeepTek CXR Analyzer |
| Company | Tempus AI | DeepTek Medical Imaging Pvt |
| Primary Modality/Input | 12-lead ECG recordings | Chest X-ray analysis |
| Target Condition/Pathology | Low Left Ventricular Ejection Fraction (LVEF u226440%) | 28 findings covering lung, pleural, cardiac pathologies, and hardware |
| Output Type | Binary output (Low LVEF Detected / Not Detected) | Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs); Generates secondary capture DICOM with AI output |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and DeepTek CXR Analyzer.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or DeepTek CXR Analyzer
Backers
Who funded each tool's parent company.